Next-generation sequencing: a breakthrough in sequencing technology
Ibrutinib and ublituximab – a promising combination regimen for treating CLL?
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
EBMT 2016 presentations overview: GvHD and metabolic syndrome
What does epigenetics mean to CLL?